Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Cirrhotic Patients

被引：0
|
作者：
Kim, J. W. [1 ]
Kim, D. Y. [2 ]
Han, K. H. [2 ]
Seong, J. [3 ]
机构：
[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiat Oncol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2387
引用
收藏
页码：E161 / E161
页数：1
相关论文
共 50 条
  • [31] Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
    Sabine Gerum
    Christian Heinz
    Claus Belka
    Franziska Walter
    Philipp Paprottka
    Enrico N. De Toni
    Falk Roeder
    Radiation Oncology, 13
  • [32] Stereotactic Body Radiation Therapy is superior to Sorafenib in terms of Survival in Patients with hepatocellular Carcinoma
    Jiang, Ping
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (02) : 188 - 189
  • [33] Predictors of Failure and Survival in Patients with Hepatocellular Carcinoma Treated with Stereotactic Body Radiation Therapy
    Arbab, M.
    Maluccio, M.
    Kong, M.
    Ellsworth, S. G.
    Rhome, R. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E212 - E213
  • [34] Racial Disparities in the Utilization of Stereotactic Body Radiation Therapy (SBRT) in Patients with Hepatocellular Carcinoma
    Du, K. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E294 - E294
  • [35] Stereotactic Ablative Body Radiation Therapy for Small Hepatocellular Carcinoma: Outcomes in 185 Patients
    Sanuki, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S321 - S321
  • [36] Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
    Gerum, Sabine
    Heinz, Christian
    Belka, Claus
    Walter, Franziska
    Paprottka, Philipp
    De Toni, Enrico N.
    Roeder, Falk
    RADIATION ONCOLOGY, 2018, 13
  • [37] Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma
    Juloori, Aditya
    Katipally, Rohan R.
    Lemons, Jeffrey M.
    Singh, Anurag K.
    Iyer, Renuka
    Robbins, Jared R.
    George, Ben
    Hall, William A.
    Pitroda, Sean P.
    Arif, Fauzia
    Fung, John
    Pillai, Anjana
    Liao, Chih-Yi
    Sharma, Manish
    Liauw, Stanley L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (01): : 202 - 213
  • [38] Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large Hepatocellular Carcinoma: Results From a Prospective Phase 2 Trial
    Buckstein, Michael
    Kim, Edward
    Ozbek, Umut
    Tabrizian, Parissa
    Gunasekaran, Ganesh
    Facciuto, Marcelo
    Rosenzweig, Kenneth
    Llovet, Josep M.
    Schwartz, Myron
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (02): : 221 - 230
  • [39] Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy
    Lasley, Foster D.
    Mannina, Edward M.
    Johnson, Cynthia S.
    Perkins, Susan M.
    Althouse, Sandra
    Maluccio, Mary
    Kwo, Paul
    Cardenes, Higinia
    PRACTICAL RADIATION ONCOLOGY, 2015, 5 (05) : E443 - E449
  • [40] Natural history of hepatocellular carcinoma after stereotactic body radiation therapy
    Mendiratta-Lala, Mishal
    Masch, William
    Owen, Dawn
    Aslam, Anum
    Maurino, Chris
    Devasia, Theresa
    Schipper, Matthew J.
    Parikh, Neehar D.
    Cuneo, Kyle
    Lawrence, Theodore S.
    Davenport, Matthew S.
    ABDOMINAL RADIOLOGY, 2020, 45 (11) : 3698 - 3708
12345